A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer

Pancreas

Volumn 31, Issue 3, 2005, Pages 258-262

  Eibl, Guido ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Pancreatic cancer; Perineural invasion; Recurrence

Indexed keywords

ABDOMINAL MASS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CACHEXIA; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; HISTOPATHOLOGY; LAPAROTOMY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PANCREAS RESECTION; PERINEURIUM; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SILVER STAINING; SURVIVAL TIME; TUMOR XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 25844482543     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000175176.40045.0f     Document Type: Article

References (31)

1. Alexakis N, Halloran C, Raraty M, et al. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91:1410-1427.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
3. Livingston EH, Welton ML, Reber HA. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol. 1991;9:153-157.
4. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
5. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
6. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221: 721-731.
7. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
8. Meyer W, Jurowich C, Reichel M, et al. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today. 2000;30:582-587.
9. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
10. Hirai I, Kimura W, Ozawa K., et al. Perineural invasion in pancreatic cancer. Pancreas. 2002;24:15-25.
11. Liu B, Lu KY. Neural invasion in pancreatic carcinoma. Hepatobiliary PancreatDis Int. 2002;1:469-476.
12. Nagakawa T, Kayahara M, Ueno K., et al. Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepatogastroenterology. 1992;39:51-55.
13. Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357-361.
14. Yi SQ, Miwa K., Ohta T, et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer. Pancreas. 2003; 27:225-229.
15. Hotz HG, Reber HA, Hotz B, et al. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas. 2003;26:e89-e98.
16. Eibl G, Takata Y, Boros LG, et al. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor. Cancer Res. 2005;65: 982-990.
17. Zagon IS, Lasher RS. A modification of the Bodian technique for embedded, frozen, and cultured nervous tissue. Trans AM Microsc Soc. 1977;96:91-96.
18. Ozaki H, Hiraoka T, Mizumoto R, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today. 1999;29:16-22.
19. Pour PM, Egami H, Takiyama Y. Patteras of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology. 1991;100:529-536.
20. Bosland MC, Prinsen MK, Dirksen TJ, et al. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2′-dimethyl- 4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res. 1990;50: 700-709.
21. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437-450.
22. Capella G, Farre L, Villanueva A, et al. Orthotopic models of human pancreatic cancer. Ann N Y Acad Sci. 1999;880:103-109;
23. Bales E, Mills L, Milam N, et al. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res. 2005;65:692-697.
24. Cabanillas R, Secades P, Rodrigo JP, et al. Orthotopic murine model of head and neck squamous cell carcinoma. Acta Otorrinolaringol Esp. 2005;56:89-95.
25. Buchler P, Reber HA, Buchler MC, et al. Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin). J Gastrointest Surg. 2001;5:139-146.
26. Buchler P, Gukovskaya AS, Mouria M, et al. Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas. 2003;26: 264-273.
27. Hotz HG, Reber HA, Hotz B, et al. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J Gastrointest Surg. 2001;5: 131-138.
28. Hotz HG, Hines OJ, Hotz B, et al. Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer. J Gastrointest Surg. 2003;7:220-227.
29. Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer. 1977;19:218-235.
30. Kyriazis AA, Kyriazis AP, Sternberg CN, et al. Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse. Cancer Res. 1986;46:5810-5815.
31. Korc M. Growth factors and pancreatic cancer. Int J Pancreatol. 1991;9: 87-91.